SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: David Bogdanoff who wrote (1046)1/26/1998 8:10:00 PM
From: Don S.Boller  Read Replies (1) | Respond to of 2173
 
David: ALSO MUST CONSIDER NEW DEALS, etc.
Certainly get no argument from me...it's just that my
favorite saying (from Will Rogers) = (when asked how he
made so much money in the stock market?) replied,
"IF THEY DON'T GO UP - DON'T BUY 'EM! I've been
watching AMLN for many months now - still waiting.
WADR,
Don



To: David Bogdanoff who wrote (1046)1/27/1998 5:25:00 AM
From: Henry Niman  Respond to of 2173
 
David, Speaking of mergers, Saturday's WSJ Interactive lists LLY and WLA as merger candidates which would be an intersting combo from the oral diabetes treatment point of view. Details in the merger section of home.att.net


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News